Establish the Caring Model of Children With Chronic Kidney Disease and End-stage Renal Disease: To Set up Childhood Glomerular Filtration Rate (GFR) Formula in Taiwan

The recruitment status of this study is unknown because the information has not been verified recently.

Verified August 2010 by China Medical University Hospital.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by:

China Medical University Hospital

ClinicalTrials.gov Identifier:

NCT01250626

First received: November 29, 2010

Last updated: November 30, 2010

Last verified: August 2010

History of Changes

Tracking Information
First Received Date ^ICMJE	November 29, 2010
Last Updated Date	November 30, 2010
Start Date ^ICMJE	August 2010
Primary Completion Date	Not Provided
Current Primary Outcome Measures ^ICMJE	Not Provided
Original Primary Outcome Measures ^ICMJE	Not Provided
Change History	Complete list of historical versions of study NCT01250626 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Establish the Caring Model of Children With Chronic Kidney Disease and End-stage Renal Disease: To Set up Childhood Glomerular Filtration Rate (GFR) Formula in Taiwan
Official Title ^ICMJE	Not Provided
Brief Summary	Inulin's usefulness as a diagnostic agent is based on the method of its elimination from the body. Inulin is biologically inert, unbound by plasma proteins, freely filtered at the glomerulus, and is neither reabsorbed, metabolized nor secreted by the kidneys. It is excreted almost entirely by glomerular filtration. Inulin clearance is considered to be identical to glomerular filtration rate (GFR).
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Case-Only Time Perspective: Prospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Non-Probability Sample
Study Population	Pediatric OPD, age < 18 y/o.
Condition ^ICMJE	Chronic Kidney Disease End-Stage Renal Disease
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	a single-group study Pediatric OPD, age < 18 y/o.
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Active, not recruiting
Enrollment ^ICMJE	80
Completion Date	Not Provided
Primary Completion Date	Not Provided
Eligibility Criteria ^ICMJE	Main inclusion criteria: Pediatric OPD, age < 18 y/o. Main exclusion criteria: Acute renal failure, edema, muscular dystrophy, pleural effusion, ascites, malnutrition, neurogenic bladder, heart failure and ketoacidosis. And taken cimetidine or trimethoprim, and accepted renal replacement therapy.
Gender	Both
Ages	up to 18 Years
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	Not Provided

Administrative Information
NCT Number ^ICMJE	NCT01250626
Other Study ID Numbers ^ICMJE	DMR99-IRB-139
Has Data Monitoring Committee	Not Provided
Responsible Party	Ching-Yuang Lin, M.D.,PhD., China Medical University
Study Sponsor ^ICMJE	China Medical University Hospital
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	China Medical University Hospital
Verification Date	August 2010
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top